Search

Your search keyword '"Turcan S"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Turcan S" Remove constraint Author: "Turcan S"
133 results on '"Turcan S"'

Search Results

1. A global research priority agenda to advance public health responses to fatty liver disease

2. Global multi-stakeholder endorsement of the MAFLD definition

3. Disease course of Crohn's disease during the first ten years following diagnosis in a prospective European population-based inception cohort - the Epi-IBD cohort

4. Disease course of Ulcerative Colitis during the first ten years following diagnosis in a prospective European population-based inception cohort - the Epi-IBD cohort

5. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort

6. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease — An ECCO-EpiCom study

7. Health care and patients' education in a European inflammatory bowel disease inception cohort: An ECCO-EpiCom study

8. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe — An ECCO-EpiCom study

9. DOP019 Immunomodulators reduce the risk of surgery and hospitalisation in Crohn’s disease in a prospective European population-based inception cohort: the Epi-IBD cohort

10. P695 The risk of proximal disease extension in patients with limited ulcerative colitis in a prospective European population-based inception cohort – the ECCO-EpiCom cohort

11. P727 Change in Crohnʼs disease behavior in a prospective European population-based inception cohort – the ECCO-EpiCom cohort

12. P694 Disease course during the first five years following diagnosis in a prospective European population-based inception cohort – the ECCO-EpiCom cohort

14. East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

15. Cost analysis in a prospective European population-based inception cohort : is there a cost-saving effect of biological therapy?

16. Immunomodulators reduce the risk of surgery and hospitalisation in Crohn’s disease in a prospective European population-based inception cohort: the Epi-IBD cohort

18. Natural disease course of inflammatory bowel disease unclassified in a prospective European population-based inception cohort-the Epi-IBD cohort

19. Immunoscore feasibility study in routine postsurgical pathologic review for early-stage colon cancer (CC) cases risk-assessment

20. Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management

21. Disease course during the first five years following diagnosis in a prospective European population-based inception cohort - the ECCO-EpiCom cohort

22. Change in Crohn's disease behavior in a prospective European population-based inception cohort - the ECCO-EpiCom cohort

23. The risk of proximal disease extension in patients with limited ulcerative colitis in a prospective European population-based inception cohort - the ECCO-EpiCom cohort

24. Frequency of anaemia and anaemia subtypes in east-west European inception cohort : an ECCO-EpiCom cohort study

25. Unchanged surgery and hospitalization rates in an East-West European inception cohort despite differences in use of biologicals-3-year follow-up of the ECCO-EpiCom cohort

26. Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort

28. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

29. The cost of investigations and medical treatment including biological therapy in a European inception cohort from the biological era : An ECCO-EpiCom study

30. Health care and patients' education in a European inflammatory bowel disease inception cohort:An ECCO-EpiCom study

31. East-West gradient in the incidence of inflammatory bowel disease in Europe:the ECCO-EpiCom inception cohort

32. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe:An ECCO-EpiCom study

33. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia:Results of the 2011 ECCO-EpiCom inception cohort

34. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease:An ECCO-EpiCom study

35. The α10 nicotinic acetylcholine receptor subunit is required for normal synaptic function and integrity of the olivocochlear system

37. Transcriptional diversity of long-term glioblastoma survivors

38. OP008 The cost of investigations and medical treatment including biological therapy in a European inception cohort from the biological era – An ECCO-EpiCom study

39. CELL BIOLOGY AND SIGNALING

40. P648 Environmental factors prior to IBD diagnosis in Europe – an ECCO–EpiCom study

43. Frequency of anaemia and anaemia subtypes in east-west European inception cohort: an ECCO-EpiCom cohort study

44. Disease course during the first five years following diagnosis in a prospective European population-based inception cohort - the ECCO-EpiCom cohort

45. Natural disease course of inflammatory bowel disease unclassified in a prospective European population-based inception cohort-the Epi-IBD cohort

46. Global multi-stakeholder endorsement of the MAFLD definition

47. Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis - An international cohort study

48. Global multi-societies endorsement of the MAFLD definition.

49. Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis.

50. Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2'-Deoxyguanosine Methylations in DNA.

Catalog

Books, media, physical & digital resources